Novo Nordisk shares slide after capital markets day targets disappoint

Novo Nordisk shares fell after the company presented new financial targets at its capital markets day, which investors judged as underwhelming relative to expectations. The drop reflects a negative market reaction to the guidance update, though the specific targets were not detailed in the source. This matters because Novo is a major European large-cap and a bellwether for the pharma sector, so the move could weigh on sector sentiment.